At 15% CAGR, Bioprocess Technology Market Size to Hit US$ 79 Billion, Globally, By 2028 | Industry Trends, Share, Growth Rate, Value, Analysis & Forecast Report By Zion Market Research – Yahoo Finance

NEW YORK, July 20, 2022 /PRNewswire/ –As per Zion Market Research study, The global bioprocess technology market size was worth over USD 18 billion in 2021 and is predicted to grow to around USD 79 billion by 2028 with a compound annual growth rate (CAGR) of roughly 15% between 2022 and 2028. 
Bioprocess Technology Market: Overview
Bioprocess technology refers to the industrial applications of biological processes that involve working on living cells or their components to reach desired substrates transformation. The advanced technology is used extensively in pharmaceuticals, fuels, chemicals, food, flavors, and other industries with the help of enzymes, microorganisms, animal cells, or plant cells in a bioreactor. Bioprocess technology is gaining more momentum as compared to traditional techniques because of its various benefits like the requirement of milder reaction conditions along with the production of renewable by-products or biomass. These technologies are more efficient and specific as compared to conventional chemical processes.
Bioprocess technology is the backbone of biotechnology since it aids the translation of life sciences into industrial products that are highly advanced. The general stages of bioprocess technology include the production of media or substrates, followed by biocatalysts that lead to volume production. The last few steps include downstream processing which entails purification-related procedures before entering the final stage of processing. The global market is witnessing a surging growth in 2 major applications of bioprocess technology, namely: fructooligosaccharides and galactooligosaccharides. They are predicted to bring tremendous changes in the food industry due to the various health benefits associated with them.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.zionmarketresearch.com/sample/bioprocess-technology-market
Our Free Sample Report Includes:
2022 Updated Report Introduction, Overview, and In-depth industry analysis
COVID-19 Pandemic Outbreak Impact Analysis Included
214 + Pages Research Report (Inclusion of Updated Research)
Provide Chapter-wise guidance on Request
2022 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
Includes Updated List of tables & figures
Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
Zion Market Research methodology
Key Industry Insights & Finding of the Bioprocess Technology Market Reports:
As per the analysis shared by our research analyst, the Bioprocess Technology Market is expected to grow annually at a CAGR of around 15 % (2022-2028).
Through the primary research, it was established that the Bioprocess Technology Market was valued approximately USD 18 Billion in 2021 and is projected to reach to roughly USD 79 Billion by 2028.
The global bioprocess technology market was dominated by North America in 2021 and is anticipated to follow the same trend owing to the increased geriatric population along with the presence of many bioprocess technology manufacturers in regions like the USA and Canada.
North America held over 85% of the global market revenue in 2021 owing to increased living standards and the corresponding disposable income of the general population encouraging them to spend on medical treatment.
Europe holds a considerable amount of global market share majorly driven due to the ever-expanding pharmaceutical sector along with rising demand for monoclonal antibodies, biosimilar, and recombinant proteins.
Realizing the safety concerns related to bioprocess technologies, various governments along with international healthcare agencies have laid down strict rules & regulations to be adhered to when working with such technologies or in organizations that employ bioprocess technology.
Zion Market Research published the latest report titled as  “Global Bioprocess Technology Market By Application (Specialty products, Environment Management Aid, Biopharmaceuticals, and Industrial Chemicals), By Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, and Virus Infiltration), By End-User (Medical Institutions, Research Laboratories & Centers, and Hospitals), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.into their research database.
Industry Dynamics:
Bioprocess Technology Market: Growth Drivers
Increased use of bioprocess technologies in the food and pharmaceutical sector to aid global market growth.
The global bioprocess technology market is projected to register higher growth in the coming years due to the extensive use of these technologies in two of the fastest-growing industries that are the food sector and the pharmaceutical sector. Since bioprocessing is a natural and one of the safest ways in which food manufacturers can manufacture items like cheese, wine, beer, bread, and yogurt that are staples in almost all diet forms, bioprocess technology has immense application in this sector. In the pharmaceutical sector, biomedical research and subsequent processes are used to pave the way for innovative pharmaceutical products which have huge implications on the healthcare sector. Since the industry is facing immense pressure due to higher demands, lesser time to deliver, and increased cost, the global market is receiving heavy input from key players to upgrade bioprocess technologies that will ultimately help them meet the growing medical needs.
The global market growth can also be attributed to the rising demand for specialized and disease-centric treatments propelling the need to invest in bioprocess therapies like cell therapy. The growing research on recombinant DNA technology which has huge utilization of bioprocess technology may also aid the expansion of the global market.
Bioprocess Technology Market: Restraints
Stringent government regulations to restrain the global market growth.
Bioprocesses can lead to serious health hazards when handled carelessly. These technologies can leave long-lasting negative implications globally in case of misuse. Realizing the safety concerns related to bioprocess technologies, various governments along with international healthcare agencies have laid down strict rules & regulations to be adhered to when working with such technologies or in organizations that employ bioprocess technology. In the food sector, the approval process before any food items are rolled out in the market is extremely strict and can lead to the shutting down of entire manufacturing units in case of malpractice which is also applicable to the pharmaceutical sector. This is expected to restrict the global market growth during the coming years.
Directly Purchase a Copy of the Report @ https://www.zionmarketresearch.com/buynow/su/bioprocess-technology-market
Bioprocess Technology Market: Opportunities
Strategic decision by market players to provide growth opportunities for global market expansion.
Since some countries have stricter laws in comparison to others, global market leaders have been adopting various strategic methods to penetrate the world market involving mergers & acquisitions, collaborations, and tie-ups, to name a few of these practices. Outsourcing the bioprocess required is a strategy showing exemplary results and is expected to provide lucrative growth opportunities in the global bioprocess technology market.
The global market may also find better growth chances owing to the rising demand for single-use bioprocess systems since they offer cost & time efficiency and can deliver better results.
Bioprocess Technology Market: Challenges
High cost of the bioprocess technology may challenge global market growth.
Large-scale bioproduction is extremely labor-intensive, requires high funds, and is time-consuming as compared to non-bioprocess technologies. This is because of the multiple variables that are involved along with many individual processes. Protein purification is one of the costliest expenses in the whole bioprocess production and comprises more than 50% of the total cost making it difficult for small-scale manufacturers to utilize the technology. In emerging economies, the cost becomes even higher since the majority of the bioprocess technology has to be imported leading to challenging situations for global market expansion.
Global Bioprocess Technology Market: Segmentation
The global bioprocess technology market is segmented by application, type, end-user, and region.
By application, the global market segments are specialty products, environment management aid, biopharmaceuticals, and industrial chemicals. Due to the rise in the number of infectious as well as chronic diseases, the global market is expected to be led by the biopharmaceutical sector. The sector contributed over USD 400 billion in 2021 and is expected to grow even more in the next few years.
By type, the global market is segmented into cell expansion, cell culture, cell line development, flow cytometry, and virus infiltration. Cell culture bioprocessing may dominate the global market due to increased research and production of therapeutic proteins in the healthcare sector.
Based on end-users, the global market is divided into medical institutions, research laboratories & centers, and hospitals. The global highest revenue may generate from the research laboratories owing to growing investments towards research on medicines, diseases, and other future biomedical problems.
Get More Insight before Buying@: https://www.zionmarketresearch.com/inquiry/bioprocess-technology-market
List of Key Players of Bioprocess Technology Market:
Lonza
GE Healthcare (General Electric Company)
Thermo Fisher Scientific
IncSartorius AG
Eppendorf AG
Dickinson and Company
Becton
Siemens Healthineers
Nova Biomedical
Advanced Instruments
F. Hoffmann-La Roche Ltd.
Danaher Corporation.
Key questions answered in this report:
What are the growth rate forecast and market size for Bioprocess Technology Market?
What are the key driving factors propelling the Bioprocess Technology Market forward?
What are the most important companies in the Bioprocess Technology Market Industry?
What segments does the Bioprocess Technology Market cover?
How can I receive a free copy of the Bioprocess Technology Market sample report and company profiles?
Report Scope:
Report Attribute
Details
Market size value in 2021
USD 18 Billion
Revenue forecast in 2028
USD 79 Billion
Growth Rate
CAGR of almost 15 % 2022-2028
Base Year
2020
Historic Years
2016 – 2021
Forecast Years
2022 – 2028
Segments Covered
By Product Type, By Application, and By End Use
Forecast Units
Value (USD Billion), and Volume (Units)
Quantitative Units
Revenue in USD million/billion and CAGR from 2022 to 2028
Regions Covered
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Companies Covered
Lonza, GE Healthcare (General Electric Company), Thermo Fisher Scientific, IncSartorius AG, Eppendorf AG, Dickinson and Company, Becton, Siemens Healthineers, Nova Biomedical, Advanced Instruments, F. Hoffmann-La Roche Ltd., and Danaher Corporation.
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope
Avail customized purchase options to meet your exact research needs.  
https://www.zionmarketresearch.com/custom/1560
Free Brochure: https://www.zionmarketresearch.com/requestbrochure/bioprocess-technology-market
Recent Developments
In September 2021, a one-of-a-kind bathroom tissue and paper towel were launched by Cascades in the USA and Canada. The bathroom products will comprise 100% recycled plastic packaging. Cascades is a leader in the circular economy, and with the launching of the new packaging systems, it intends to reduce the environmental impacts of its operations. The launch was accompanied by excellent promotional campaigns.
In November 2020, LTC Group was acquired by Accrol. LTC Group manufactures tissue converters. With this acquisition, Accrol intends to increase the good scale business with the help of modern machine assets that are high-quality and will aid the day-to-day operations.
Regional Dominance:
North America to provide excellent growth opportunities during the forecast period.
The global bioprocess technology market was dominated by North America in 2021 and is anticipated to follow the same trend owing to the increased geriatric population along with the presence of many bioprocess technology manufacturers in regions like the USA and Canada. North America held over 85% of the global market revenue in 2021 owing to increased living standards and the corresponding disposable income of the general population encouraging them to spend on medical treatment. The regional growth may also be attributed to the advanced economy and growing funding for research activities.
Europe holds a considerable amount of global market share majorly driven due to the ever-expanding pharmaceutical sector along with rising demand for monoclonal antibodies, biosimilar, and recombinant proteins. The region may also witness high growth because of excellent medical reimbursement policies.
Global Bioprocess Technology Market is segmented as follows:
Bioprocess Technology Market: By Application Outlook (2022-2028)
Specialty products
Environment Management Aid
Biopharmaceuticals
Industrial chemicals
Bioprocess Technology Market: By Type Outlook (2022-2028)
Cell Expansion
Cell Culture
Cell Line Development
Flow Cytometry
Virus Infiltration
Bioprocess Technology Market: By End-User Outlook (2022-2028)
Medical Institutions
Research Laboratories & Centers
Hospitals
Bioprocess Technology Market: By Region Outlook (2022-2028)
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
Press Release For Bioprocess Technology Market: https://www.zionmarketresearch.com/news/global-bioprocess-technology-market
Browse Other Related Research Reports from Zion Market Research
Endocrine Peptide Test Market – Global Industry Analysis: The global endocrine peptide test market was worth around $7.04 billion in 2021 and is predicted to grow to around $11 billion by 2028 at a CAGR rate of 8% over the forecast period.
Hospital-Acquired Infection Control Market – Global Industry Analysis: The global hospital-acquired infection control market was valued at USD 28.99 billion in 2021. The global market is projected to grow to about USD 34.03 billion at a CAGR of 9.89% by 2028.
Healthcare E-Commerce Market – Global Industry Analysis: The global Healthcare E-Commerce Market accrued earnings worth approximately 353.1 (USD Billion) in 2020 and is predicted to gain revenue of about 840.1 (USD Billion) by 2028, is set to record a CAGR of nearly 17.1% over the period from 2021 to 2028.
Browse through Zion Market Research’s coverage of the Global Healthcare Industry
Follow Us on: LinkedIn | Twitter | Facebook
About Us
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research 
244 Fifth Avenue, Suite N202 
New York, 10001, United States 
Tel: +49-322 210 92714 
USA/Canada Toll Free No.1-855-465-4651 
Email: sales@zionmarketresearch.com 
Website: https://www.zionmarketresearch.com/
Blog: https://techpru.com/ | http://thehealthypandas.com/
Logo: https://mma.prnewswire.com/media/1605489/Zion_Market_Research_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/at-15-cagr-bioprocess-technology-market-size-to-hit-us-79-billion-globally-by-2028–industry-trends-share-growth-rate-value-analysis–forecast-report-by-zion-market-research-301590183.html
SOURCE Zion Market Research
Warren Buffett has accumulated a nearly 20% stake in Occidental Petroleum over the last several months. So: what's the Oracle of Omaha's endgame?
Anthony Scaramucci, the short-lived White House communications director under Donald Trump, is a bitcoin evangelist.
Verizon stock is moving lower after an earnings miss and dip in wireless subscriber growth.
(Bloomberg) — The housing market correction that’s taking hold in Canada could turn out to be its biggest in recent history, according to a new forecast from the country’s largest bank.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTesla’s Bitcoin Dump Leaves Accounting Mystery in Its WakeTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedStudent Loan Borrowers Aren’t Waiting for Biden’s Promised ReliefUkraine Latest: US Opens Door to S
Snap Inc. has never been an investor-friendly company as long as those investors weren't their founders, and the parent company of the Snapchat app made that even clearer Thursday.
Snap's 40% stock price crash on Friday after a dismal second quarter earnings report and brutal call is well warranted, one analysts explained to Yahoo Finance.
Jim Cramer is a lightning rod when it comes to scrutiny. On one hand, giving investing advice every day on air for years is naturally going to produce some losing picks. However, Cramer has become the focal point of a lot of targeted opposition. For instance, you can check out his ongoing (albeit one-sided) feud with George Noble, who is quick to call out Cramer. Or, you could check out the Journal of Retirement’s in-depth study of Cramer’s Charitable Trust performance and see that “Cramer’s por
This money management maven doesn't mince words when it comes to what you shouldn’t be doing with your money.
While 2022 has undoubtedly been a rough time in the market, it's given us an opportunity to buy high-quality companies at a discount. The rebound will be massive, and bears will flee.
(Bloomberg) — Volkswagen AG ousted Herbert Diess, the architect of the auto industry’s biggest electrification effort, after clashes with labor unions and execution issues left the chief executive without support of key stakeholders.Most Read from BloombergThree Arrows Founders Break Silence Over Collapse of Crypto Hedge FundTesla’s Bitcoin Dump Leaves Accounting Mystery in Its WakeTrump Insiders Recall How He Spurned Pleas to Act as Riot RagedStudent Loan Borrowers Aren’t Waiting for Biden’s P
Just where is the stock market going, that’s the question investors are trying to answer. The answer isn’t fully clear, though; markets have fallen for most of this year, but the last few days have seen the best trading in weeks. The problem is, investors and economists aren’t sure if we’re at a true bottom or just in the midst of a bear market rally. What happens next is anyone’s guess, but the history of bears and rallies can offer some suggestions. Looking back to the end of the Second World
The energy industry had some of the hottest stocks on the market over the past two years, but with fears of a recession potentially dampening demand for oil and gas, the S&P 500 Energy index is down 25% since its peak last month. The cost of a barrel of oil is down to around $100 per barrel, and gasoline at the pumps has broken from its record high last month of $5 a gallon.
Everyone knows that chasing violent storms is risky for your life. But it turns out that yield chasing in the S&P 500 can be risky for your money.
These remarkable growth stocks are begging to be bought following a peak decline of 34% in the Nasdaq.
Stock-market bulls are poking their heads above the parapet, but skeptics see little more than a bear-market bounce.
U.S. stocks were under pressure Friday afternoon as a disastrous quarter from Snap weighed on the broader tech sector.
Q.: My wife inherited a 401(k) from my mom who died recently. Assuming this is a traditional 401(k), you are correct that whatever comes out of the account will be likely be taxable to you. Transfer your wife’s share of the money to an Inherited 401(k) with the company that held your mom’s 401(k).
The Dow Jones fought back. Tesla stock rocketed after Elon Musk gave an update on its "best product ever." Apple stock popped. Bitcoin fell.
Investment giant JPMorgan’s chief global market strategist Marko Kolanovic notes that the first quarter of this year saw an incredible $429 billion in total buyback activity. This represents a faster pace than both of the previous two years, and reflected a combination of healthy margins and strong corporate cash flows. That fundamental strength allowed corporations to step up and start buying even as the Federal Reserve stepped back by tightening up on monetary policy. Kolanovic notes that not
GlaxoSmithKline (GSK) closed at $42.29 in the latest trading session, marking a +0.09% move from the prior day.

source

Leave a Comment